Literature DB >> 23780982

Gemcitabine with paclitaxel therapy against mesocolic leiomyosarcoma: a case report.

Tomoaki Mizobe1, Yoshito Akagi, Hiroto Ishikawa, Ichitaro Shiratsuchi, Yosuke Oka, Tetsushi Kinugasa, Kouichi Ohshima, Kozo Setojima, Kazuo Shirouzu.   

Abstract

A 65-year-old man complained of lower right abdominal pain, and an intra-abdominal mass was identified. An intra-abdominal hemorrhage was discovered during a thorough examination and emergency surgery was performed. The tumor was ruptured and was fragile, making it difficult to perform extirpation; thus, an ileocecal resection was performed. The histopathological diagnosis of the tumor was leiomyosarcoma, and recurrence was observed during the early postoperative period. The patient underwent surgery twice; each time there was a recurrence, but complete resection could not be obtained, and paclitaxel and gemcitabine chemotherapy was performed. A temporary effect was observed, and control of disease progression lasted approximately five months. Standard chemotherapy for leiomyosarcoma has not been established, but this method could become a therapeutic strategy for leiomyosarcoma.

Entities:  

Keywords:  Leiomyosarcoma; chemotherapy; gemcitabine; mesocolic; paclitaxel; recurrence

Mesh:

Substances:

Year:  2013        PMID: 23780982

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Curative resection for leiomyosarcoma of the descending mesocolon with metachronous liver metastasis: A case report and literature review.

Authors:  Takaharu Kato; Hiroshi Noda; Iku Abe; Sergio Alonso; Nobu Yokoyama; Toshiki Rikiyama
Journal:  Mol Clin Oncol       Date:  2016-04-25

2.  DOG1-Positive Primary Mesenteric Leiomyosarcoma: Report of a Case and Review of the Literature.

Authors:  Nektarios Koufopoulos; Vasileia Damaskou; Vasiliki Siozopoulou; Panagiotis Kokoropoulos; Alina-Roxani Gouloumis; Nikolaos Arkadopoulos; Ioannis G Panayiotides
Journal:  Cureus       Date:  2022-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.